Diabetes :: Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
Diabetes mellitus is a medical disorder characterized by varying or persistent hyperglycemia (elevated blood sugar levels), especially after eating. Hyperglycemia itself can lead to dehydration and ketoacidosis. Longer-term complications include cardiovascular disease (doubled risk), chronic renal failure, retinal damage with eventual blindness, nerve damage, etc.
logo - spiritindia - Diabetes :: Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes

Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes

Diabetes :: Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes

Diabetes :: Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes

The largest-ever study of treatments for type 2 diabetes has shown that a combination of two blood pressure lowering drugs reduced the risk of death, as well as the risks of heart and kidney disease.

The ADVANCE (Action in Diabetes and Vascular Disease) Study was led by researchers at The George Institute for International Health in Sydney and the results have been presented at the European Congress of Cardiology in Vienna.

One of the study leaders, Professor Stephen MacMahon, Principal Director of The George Institute, said "These results represent an important step forward in the care of people with type 2 diabetes worldwide. This treatment reduced the likelihood of dying from the complications of diabetes by almost one-fifth, and could potentially save several millions of lives over the next decade if the treatment was widely implemented.?

More than 600,000 Australians and more than 250 million people worldwide have type 2 diabetes, and most will eventually die or be disabled by the complications. The most common cause of death is heart disease, but kidney disease also affects a large proportion. In 2006, the United Nations called for increased international action to combat the global epidemic of diabetes.

More than 11,000 patients with type 2 diabetes in 20 countries world wide participated in the 4.3 year project. Half received daily treatment with a single tablet containing a fixed combination of two blood pressure lowering drugs (perindopril plus indapamide) and half received matching inactive placebo.

?Importantly, the ADVANCE results showed that patients with type 2 diabetes benefited from this blood pressure lowering treatment irrespective of whether or not their blood pressure was elevated to begin with,? said study investigator, Dr Bruce Neal, of The George Institute,

?The participants in ADVANCE were already receiving most of the usual treatments provided to patients with diabetes, including other drugs to lower blood pressure,? explained Dr. Anushka Patel, of The George Institute and the ADVANCE Study Director. ?However, the addition of the fixed combination of perindopril and indapamide reduced the risk of death from any cause by 14% and the risk of death from cardiovascular disease by 18%. Over 5 years, this treatment would prevent one death among every 80 patients treated.?

?The results clearly demonstrate that we have the tools to blunt the impact of the global diabetes epidemic facing rich and poor countries alike. But concerted action is urgently required to ensure that patients with diabetes are identified and provided with treatments proven to improve important outcomes like survival,? added Professor John Chalmers, the author of international guidelines for the treatment of high blood pressure and chairman of the study management group.




(Diabetes :: Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes published at SpiritIndia on Wednesday, September 5, 2007)



Diabetes

Search more information on Diabetes, Diabetes books

Recently posted related articles on Diabetes :

  1. Diabetes :: 63 percent of diabetics risk serious foot problems by wearing the wrong-sized shoes
  2. Diabetes :: India to launch special programme to control diabetes
  3. Diabetes :: Stanford researchers shed light on gestational diabetes
  4. Diabetes :: The new source of islet cells
  5. Diabetes :: European Medicine Agency confirms positive Avandia benefit risk assessment
  6. Pancreatitis :: Diabetes drug Byetta, exenatide may cause acute pancreatitis
  7. Diabetes :: PGC-1-alpha helps skeletal muscle and pancreatic islets communicate
  8. Blood Pressure :: Women with high or increasing blood pressure are up to three times more likely to develop diabetes
  9. Diabetes :: New IDF guidelines raise importance of post-meal glucose control
  10. Diabetes :: Solving a critical part of the insulin puzzle

Most related articles:

- Diabetes :: Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
- Diabetes :: More Australian children developing type 1 diabetes - 15.7
- Diabetes :: Blood pressure drug combo diuretic plus ACE inhibitor reduces heart disease risk in diabetes patients - 13.5
- Diabetes :: New blood pressure medicines are less diabetes risky - 12.3
- Diabetes :: Type 2 diabetes an indicator of serious underlying issues in our society - 11.8
- Diabetes :: Glaxo's diabetes drug beats older rivals - 11.5
- Diabetes :: Waisty issues for National Diabetes Week, Australia - 11.2
- Diabetes :: Weight loss surgery helps prevent diabetes - 10.8
- Diabetes :: Gestational diabetes raises future diabetes risk - 10.7
- Diabetes :: World Diabetes Day - November 14 - Australia - 10.6


Diabetes - recent related articles/news stories:

- Gene Deaf1 may play a role in type 1 diabetes
- Pancreatic cancer risk reduced by diabetes drug metformin
- Low birth weight linked to diabetes gene CDKAL1
- Treating obesity with brown fat in the body
- Antipsychotics raise blood sugar in older diabetes patients

»»   Health :: Open access to health research publications
««   Smoking :: Smoking in movies make teens active smokers






Tools
Daily calorie need
Homeo tips
Homeo softwares
Associations
NHMC Alumni
IFH
PHS
Vital Informer
Articles & news
Education
Homeo articles
Homeopathy cases
Homeopathic Remedies
You
Authors
Submit article
Your account
Testimonials
About
About us
Advertisers
Advertising
Linking us
Disclaimer
Privacy policy

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com